scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1112641405 |
P356 | DOI | 10.1038/S41419-019-1319-5 |
P932 | PMC publication ID | 6408495 |
P698 | PubMed publication ID | 30850581 |
P50 | author | Andreas Linkermann | Q30225182 |
Stephan Immenschuh | Q47158608 | ||
Rainer Blasczyk | Q85026471 | ||
P2093 | author name string | Jan Ulrich Becker | |
Vijith Vijayan | |||
Constanca Figueiredo | |||
Abid Aljabri | |||
Christoph Nikolin | |||
Metodi Stankov | |||
P2860 | cites work | How mitochondria produce reactive oxygen species | Q24643882 |
Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms | Q27314948 | ||
Cell biology. Metabolic control of cell death | Q28397089 | ||
Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells | Q30489241 | ||
Endothelial injury in renal antibody-mediated allograft rejection: a schematic view based on pathogenesis | Q33405640 | ||
Regulated necrosis: the expanding network of non-apoptotic cell death pathways. | Q34039639 | ||
Necroptosis | Q34039704 | ||
Effect of antibodies on endothelium | Q35547335 | ||
Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation | Q35874401 | ||
Citreoviridin Induces Autophagy-Dependent Apoptosis through Lysosomal-Mitochondrial Axis in Human Liver HepG2 Cells | Q35996611 | ||
Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. | Q36111729 | ||
Origin and Consequences of Necroinflammation | Q49714401 | ||
Mitochondria-lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis. | Q49821305 | ||
Semaphorin 3A alters endothelial cell immunogenicity by regulating Class II transactivator activity circuits. | Q50458797 | ||
Mechanisms of rejection: current perspectives. | Q50979807 | ||
Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. | Q51038604 | ||
HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection. | Q52373711 | ||
Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody. | Q53459320 | ||
HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes | Q73128519 | ||
De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival | Q83159507 | ||
Antibody-mediated organ-allograft rejection | Q36263023 | ||
HLA class I-mediated stress fiber formation requires ERK1/2 activation in the absence of an increase in intracellular Ca2+ in human aortic endothelial cells | Q36312784 | ||
Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion | Q36370419 | ||
Antibody and complement in transplant vasculopathy | Q36726080 | ||
A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody | Q36887068 | ||
Mitochondria and endothelial function | Q36979168 | ||
Impact of innate and adaptive immunity on rejection and tolerance | Q37293088 | ||
Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts | Q37445163 | ||
A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC. | Q37603481 | ||
Rejection of the kidney allograft | Q37798268 | ||
Immunological function of the endothelial cell within the setting of organ transplantation. | Q37885017 | ||
The role of complement in antibody-mediated rejection in kidney transplantation | Q38048605 | ||
Lysosomal cell death at a glance. | Q38110528 | ||
Surviving apoptosis: life-death signaling in single cells. | Q38446898 | ||
Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species. | Q38631756 | ||
Lysosomal membrane permeabilization in cell death: new evidence and implications for health and disease | Q38645410 | ||
Regulated necrosis: disease relevance and therapeutic opportunities | Q38699324 | ||
The in vivo evidence for regulated necrosis | Q38809791 | ||
Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria | Q38862588 | ||
Transplantation and Damage-Associated Molecular Patterns (DAMPs). | Q38898214 | ||
DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing. | Q38928826 | ||
Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase | Q39096709 | ||
Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection | Q39131000 | ||
HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs | Q39149436 | ||
Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies | Q39366396 | ||
Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway | Q39392738 | ||
Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. | Q39746539 | ||
HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion | Q40266578 | ||
Antibodies against dengue virus nonstructural protein-1 induce heme oxygenase-1 via a redox-dependent pathway in human endothelial cells | Q40270075 | ||
Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells | Q40421753 | ||
SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide | Q40575818 | ||
Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide | Q40579380 | ||
Delineation of the HLA-DR region and the residues involved in the association with the cytoskeleton | Q40587553 | ||
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss | Q40634986 | ||
Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts | Q40659031 | ||
Role of Sphingosine-1-Phosphate in Transplant Vasculopathy Evoked by Anti-HLA Antibody | Q40990718 | ||
Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor β. | Q43240966 | ||
Mitochondria control of cell death induced by anti-HLA-DR antibodies | Q44497849 | ||
MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways | Q44526947 | ||
Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies | Q45197912 | ||
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease | Q46292537 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
cell death | Q2383867 | ||
P304 | page(s) | 235 | |
P577 | publication date | 2019-03-08 | |
P1433 | published in | Cell Death and Disease | Q2197222 |
P1476 | title | HLA class II antibodies induce necrotic cell death in human endothelial cells via a lysosomal membrane permeabilization-mediated pathway | |
P478 | volume | 10 |
Q90093164 | Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion |
Q90532382 | Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies |
Q95840792 | Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells |
Search more.